ReviewCureus2026
Quality of Life After Heart Transplantation: Instruments, Domains, and Variations by Time, Age, and Gender.
Review in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Quality of life (QoL) has become a central outcome in heart transplantation, complementing traditional metrics of graft survival and clinical morbidity. As advances in surgical technique and immunosuppression have extended posttransplant longevity, understanding how patients function and experience daily life has gained increasing clinical relevance. The objective of this review is to synthesize contemporary evidence on QoL across the physical, psychological, social, and treatment-related domains, with particular emphasis on how these dimensions evolve over early, intermediate, and long-term follow-up. We summarize established tools for assessing QoL, highlight key determinants in each domain, and describe how factors such as exercise capacity, emotional recovery, social reintegration, and immunosuppressive burden contribute to the patient experience over time. Special attention is given to the limited but growing data on long-term survivors, whose QoL trajectories reveal both sustained benefits and emerging challenges decades after transplantation. Together, this review provides a comprehensive overview of current knowledge and outlines what clinicians and researchers can expect when evaluating QoL in heart transplant recipients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.